Q1 Earnings Forecast for Waters Issued By KeyCorp

Waters Co. (NYSE:WAT) – KeyCorp issued their Q1 2025 earnings per share estimates for Waters in a report released on Monday, March 31st. KeyCorp analyst P. Knight expects that the medical instruments supplier will post earnings of $2.20 per share for the quarter. KeyCorp currently has a “Overweight” rating and a $460.00 price target on the stock. The consensus estimate for Waters’ current full-year earnings is $12.86 per share. KeyCorp also issued estimates for Waters’ Q2 2025 earnings at $2.88 EPS, Q3 2025 earnings at $3.23 EPS, Q4 2025 earnings at $4.45 EPS and FY2026 earnings at $13.83 EPS.

Waters (NYSE:WAT) last announced its quarterly earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 EPS for the quarter, topping the consensus estimate of $4.02 by $0.08. Waters had a net margin of 21.56% and a return on equity of 46.31%.

Several other brokerages also recently weighed in on WAT. JPMorgan Chase & Co. raised their target price on Waters from $380.00 to $390.00 and gave the company a “neutral” rating in a research note on Thursday, March 6th. Scotiabank raised shares of Waters from a “sector perform” rating to a “sector outperform” rating and upped their price objective for the company from $430.00 to $450.00 in a research note on Thursday, February 13th. Robert W. Baird raised shares of Waters from a “neutral” rating to an “outperform” rating and raised their price objective for the company from $396.00 to $407.00 in a research report on Wednesday, March 26th. StockNews.com cut Waters from a “buy” rating to a “hold” rating in a research report on Tuesday, February 25th. Finally, Bank of America dropped their price target on shares of Waters from $430.00 to $410.00 and set a “neutral” rating for the company in a research report on Thursday, February 13th. Ten equities research analysts have rated the stock with a hold rating, seven have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $401.31.

Waters Stock Up 1.8 %

WAT opened at $368.53 on Tuesday. The firm has a market cap of $21.89 billion, a P/E ratio of 34.41, a PEG ratio of 3.79 and a beta of 1.00. The company has a quick ratio of 0.65, a current ratio of 0.94 and a debt-to-equity ratio of 1.14. Waters has a 52 week low of $279.24 and a 52 week high of $423.56. The business’s fifty day simple moving average is $386.70 and its 200 day simple moving average is $373.25.

Institutional Trading of Waters

A number of hedge funds and other institutional investors have recently bought and sold shares of WAT. Vanguard Group Inc. boosted its stake in shares of Waters by 0.3% in the 4th quarter. Vanguard Group Inc. now owns 7,098,668 shares of the medical instruments supplier’s stock valued at $2,633,464,000 after purchasing an additional 19,456 shares in the last quarter. Wealthfront Advisers LLC increased its position in shares of Waters by 106,144.4% during the fourth quarter. Wealthfront Advisers LLC now owns 3,087,461 shares of the medical instruments supplier’s stock valued at $1,145,386,000 after buying an additional 3,084,555 shares during the period. Alliancebernstein L.P. lifted its stake in shares of Waters by 8.7% in the 4th quarter. Alliancebernstein L.P. now owns 2,654,002 shares of the medical instruments supplier’s stock valued at $984,582,000 after purchasing an additional 212,364 shares during the period. State Street Corp grew its position in shares of Waters by 1.9% in the 3rd quarter. State Street Corp now owns 2,577,733 shares of the medical instruments supplier’s stock worth $927,700,000 after buying an additional 49,194 shares during the period. Finally, Geode Capital Management LLC grew its holdings in Waters by 2.5% in the fourth quarter. Geode Capital Management LLC now owns 1,451,445 shares of the medical instruments supplier’s stock worth $537,053,000 after purchasing an additional 34,762 shares during the period. Institutional investors own 94.01% of the company’s stock.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.